PedAM
Pediatric Disease Annotations & Medicines
| Disease | atrial fibrillation |
| Phenotype | C0011847|diabetes |
| Sentences | 27 |
| PubMedID- 22016590 | Statins have shown additional pleiotropic effects beyond their lipid-lowering effect; they improve endothelial function, reduce inf lammation and coronary artery thrombus, and decrease left-ventricular mass, blood pressure, left-ventricular fibrosis, cardiac-valve sclerosis, atrial fibrillation, and mortality in patients with diabetes and renal disease [6-11]. |
| PubMedID- 26476086 | Background: there are no proven strategies to prevent atrial fibrillation (af) in patients with type 2 diabetes (t2dm). |
| PubMedID- 26147101 | The exclusion criteria were myocardial infarction (evaluated by q waves on an electrocardiogram (ecg) or segmental left ventricular (lv) dysfunction by 2-dimensional echocardiography), moderate or severe valvar heart disease (evaluated by clinical examination and by doppler echocardiography), arterial hypertension, smoking, diabetes mellitus, current use of statins, atrial fibrillation, advanced atrioventricular block, pacemaker, thyroid diseases, chronic obstructive pulmonary disease, and heart failure functional classes iii and iv by the new york heart association (nyha) classification. |
| PubMedID- 23273718 | Relation of heart-rate recovery to new onset heart failure and atrial fibrillation in patients with diabetes mellitus and preserved ejection fraction. |
| PubMedID- 20405332 | Among those with treated diabetes, the risk of developing atrial fibrillation was 3% higher for each additional year of diabetes duration (95% ci 1-6%). |
| PubMedID- 24699792 | atrial fibrillation in patients with diabetes mellitus type 2 identifies individuals who are likely to obtain greater benefits from glycemic control and anticoagulants as well as antihypertensive therapy. |
| PubMedID- 21747831 | Therefore, atrial fibrillation pattern in patients with diabetes should be regarded as a prognostic marker of adverse outcome and prompt aggressive management of all risk factors is required [30]. |
| PubMedID- 26498716 | Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis. |
| PubMedID- 26353872 | Risk factors included age, body mass index (bmi), systolic blood pressure, cholesterol/ high-density lipoprotein (hdl) ratio, glycosylated haemoglobin (hba1c), material deprivation, ethnicity, smoking, diabetes duration, type of diabetes, atrial fibrillation, cardiovascular disease, chronic renal disease, and family history of premature coronary heart disease. |
| PubMedID- 21985750 | Incidence of new onset bundle branch block and atrial fibrillation in patients with type 2 diabetes and macrovascular disease: an analysis of the proactive study. |
| PubMedID- 25827533 | Nine predictors (coronary artery disease, diabetes mellitus, hypertension, history of cerebrovascular disease, atrial fibrillation, smoking, the findings of carotid doppler ultrasonography [normal, plaque, plaque+stenosis>/=50%], the levels of cholesterol and c-reactive protein) were used for predicting the stroke. |
| PubMedID- 20822544 | Multivariate analysis was performed after adjusting for age, diabetes, smoking, history of cvd, atrial fibrillation, lvh and sbp. |
| PubMedID- 26254188 | The aim of our study was to investigate the risk of atrial fibrillation in patients with diabetes compared to the background population in denmark. |
| PubMedID- 23990675 | Older age, female sex, african american race and hispanic ethnicity, unemployed status, diabetes, hypertension, history of stroke, and permanent atrial fibrillation were positively associated with ischemic stroke, whereas body mass index >30 kg/m(2) was inversely associated with stroke (p<0.001 for each). |
| PubMedID- 24059905 | The risk factors for ischemic stroke include aging, hypertension, diabetes, smoking, history of cardiovascular diseases, atrial fibrillation, and left ventricular hypertrophy [8,9]. |
| PubMedID- 20659042 | [atrial fibrillation in patients with type 2 diabetes mellitus: specific features of development and antirecurrence therapy]. |
| PubMedID- 22981550 | Type 2 diabetes mellitus and risk of incident atrial fibrillation in women. |
| PubMedID- 20937975 | No clinical parameters such as age, hypertension, diabetes mellitus, previous history of stroke, type of atrial fibrillation, and preablation antithrombotic treatment showed significant correlation with ischemic cerebral embolism. |
| PubMedID- 23901296 | After multivariate adjustment for the sociodemographic characteristics, comorbidities, hospital clinical complications, and admission physiologic variables included in table 1, factors significantly associated with an adverse long-term prognosis following hospital discharge for patients with stemi included older age, longer hospital stay, previously diagnosed heart failure, diabetes or stroke, development of atrial fibrillation during hospitalization, elevated systolic blood pressure and blood glucose findings at the time of hospital admission, and lower serum estimated gfr findings (table 2). |
| PubMedID- 23576900 | Mechanism of and therapeutic strategy for atrial fibrillation associated with diabetes mellitus. |
| PubMedID- PMC4125833 | The study is expected to give detailed information on the increased prevalence of atrial fibrillation in patients with type 2 diabetes and provides the data base for an optimized therapy regime in order to avoid cardio-vascular complications. |
| PubMedID- 23672990 | Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus. |
| PubMedID- 25192283 | Methods: in this prospective cohort study, 2,144 hong kong chinese with type 2 diabetes and without history of stroke or atrial fibrillation were recruited in 1994-1996 and followed up for a median of 14.51 years. |
| PubMedID- 20550690 | The risk factors were presented in the questionnaire in the following order: higher age, hyperlipidemia, diabetes, a family history of cardiovascular disease, atrial fibrillation, hypertension, overweight, regular physical exercise, excessive alcohol consumption, previous stroke/tia, carotid stenosis, smoking and ischaemic heart disease. |
| PubMedID- 21094363 | Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation associated with diabetes mellitus or impaired fasting glucose. |
| PubMedID- 22250063 | The ukpds risk engine includes age, diabetes duration, sex, presence of atrial fibrillation, ethnicity, smoking status, hba1c (%), systolic bp (mmhg), total cholesterol (mmol/l), and hdl-c (mmol/l). |
| PubMedID- 26064216 | Elevated glycated hemoglobin levels may increase the risk of atrial fibrillation in patients with diabetes mellitus. |
Page: 1